UK shareholder meetings calendar - next 7 days
10th Mar 2026 12:15
N4 Pharma Plc (N4P) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 543,479 | 0.46p | Ordinary |
16:21:32 - 17-Mar-26 |
| Buy* | 37,600 | 0.49p | Ordinary |
09:48:58 - 17-Mar-26 |
| Sell* | 222 | 0.45p | SI Trade |
11:41:31 - 16-Mar-26 |
| Buy* | 200 | 0.50p | SI Trade |
11:41:31 - 16-Mar-26 |
| Buy* | 4,712 | 0.50p | SI Trade |
11:41:31 - 16-Mar-26 |
| Sell* | 686 | 0.45p | SI Trade |
11:41:31 - 16-Mar-26 |
| Buy* | 7,000 | 0.50p | SI Trade |
11:41:31 - 16-Mar-26 |
| Sell* | 1,000 | 0.45p | SI Trade |
11:41:31 - 16-Mar-26 |
| Buy* | 8,866 | 0.50p | SI Trade |
14:53:24 - 13-Mar-26 |
| Sell* | 1,700 | 0.45p | SI Trade |
14:53:24 - 13-Mar-26 |
N4 Pharma Plc (N4P) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 17th Mar 2026 12:14 pm | RNS | Result of General Meeting and Change of Name |
| 27th Feb 2026 7:00 am | RNS | Notice of GM and Proposed Change of Name |
| 24th Feb 2026 7:00 am | RNS | CEO Appointment & Name Change Thalia Therapeutics |
| 17th Dec 2025 7:00 am | RNS | Business and Operational Update |
| 25th Sep 2025 7:00 am | RNS | Interim Results |
| 23rd Sep 2025 7:00 am | RNS | Partnership with University of Strathclyde’s CMAC |
| 22nd Sep 2025 7:00 am | RNS | N4 Pharma’s Nuvec® Targets Lung Cancer Cells |
| 19th Sep 2025 7:00 am | RNS | Notice of Results, Analyst & Investor Presentation |
| 11th Sep 2025 7:00 am | RNS-R | Investor Event and Presentation |
| 30th Jul 2025 1:55 pm | RNS-R | Article on Nuvec®’s Potential in RNA Therapeutics |